Shigetaka Shimodaira

9PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersBiomechanicsCancer diagnosisMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 31, 2025
Predictors of patients with advanced pancreatic cancer undergoing conversion surgery via chemoimmunotherapy with a multifunctional Wilms' tumor 1 (WT1) peptide cocktail-pulsed dendritic cell vaccine.

Shigeo Koido, Junichi Taguchi, Masamori Shimabuku

|Jul 29, 2023
Clinical Trial on the Safety and Tolerability of Personalized Cancer Vaccines Using Human Platelet Lysate-Induced Antigen-Presenting Cells.

Terutsugu Koya, Kenichi Yoshida, Misa Togi

|Jan 21, 2023
Synovial Fluid Derived from Human Knee Osteoarthritis Increases the Viability of Human Adipose-Derived Stem Cells through Upregulation of FOSL1.

Hironori Kitajima, Takuya Sakamoto, Tetsuhiro Horie

|Oct 27, 2022
The Detection of Immunity against WT1 and SMAD4P130L of EpCAM+ Cancer Cells in Malignant Pleural Effusion.

Terutsugu Koya, Yo Niida, Misa Togi

|Aug 12, 2022
Different In Vitro-Generated MUTZ-3-Derived Dendritic Cell Types Secrete Dexosomes with Distinct Phenotypes and Antigen Presentation Potencies.

Takuya Sakamoto, Terutsugu Koya, Misa Togi

|Feb 15, 2022
Evaluation of the Usefulness of Human Adipose-Derived Stem Cell Spheroids Formed Using SphereRing® and the Lethal Damage Sensitivity to Synovial Fluid In Vitro.

Atsushi Fuku, Yasuhiko Taki, Yuka Nakamura

Pageof 2

Frequent Collaborators

5 joint publications

Takuya Sakamoto

5 joint publications

Misa Togi

4 joint publications

Yasuhito Ishigaki

3 joint publications

Sohsuke Yamada